{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:03:29Z","timestamp":1777982609294,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00533-8","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:59:26Z","timestamp":1770638366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single institution assessment of physician compliance and patient uptake with guideline directed aspirin therapy in the prevention of colorectal cancer in lynch syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Alexandra","family":"Yudiski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Dzeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Granja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Shermanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Leicht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Morland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Confer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"02","key":"533_CR1","doi-asserted-by":"publisher","first-page":"063","DOI":"10.1055\/s-0032-1313776","volume":"25","author":"B Bansidhar","year":"2012","unstructured":"Bansidhar B, Silinsky J (2012) History and pathogenesis of Lynch Syndrome. Clin Colon Rectal Surg 25(02):063\u2013066. https:\/\/doi.org\/10.1055\/s-0032-1313776","journal-title":"Clin Colon Rectal Surg"},{"issue":"6","key":"533_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.dld.2012.10.006","volume":"45","author":"B Buecher","year":"2013","unstructured":"Buecher B, Cacheux W, Rouleau E, Dieumegard B, Mitry E, Li\u00e8vre A (2013) Role of microsatellite instability in the management of colorectal cancers. Dig Liver Dis 45(6):441\u2013449. https:\/\/doi.org\/10.1016\/j.dld.2012.10.006","journal-title":"Dig Liver Dis"},{"issue":"22","key":"533_CR3","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch Syndrome. JAMA 305(22):2304. https:\/\/doi.org\/10.1001\/jama.2011.743","journal-title":"JAMA"},{"issue":"12","key":"533_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K (2016) Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 164(12):836\u2013845. https:\/\/doi.org\/10.7326\/M16-0577","journal-title":"Ann Intern Med"},{"issue":"10152","key":"533_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","volume":"392","author":"JM Gaziano","year":"2018","unstructured":"Gaziano JM, Brotons C, Coppolecchia R et al (2018) Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet 392(10152):1036\u20131046. https:\/\/doi.org\/10.1016\/S0140-6736(18)31924-X","journal-title":"Lancet"},{"issue":"3","key":"533_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/jnci\/djaa114","volume":"113","author":"JJ McNeil","year":"2021","unstructured":"McNeil JJ, Gibbs P, Orchard SG et al (2021) Effect of aspirin on cancer incidence and mortality in older adults. JNCI J Natl Cancer Inst 113(3):258\u2013265. https:\/\/doi.org\/10.1093\/jnci\/djaa114","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"16","key":"533_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/jama.2022.3337","volume":"327","author":"JM Guirguis-Blake","year":"2022","unstructured":"Guirguis-Blake JM, Evans CV, Perdue LA, Bean SI, Senger CA (2022) Aspirin use to prevent cardiovascular disease and colorectal cancer. JAMA 327(16):1585. https:\/\/doi.org\/10.1001\/jama.2022.3337","journal-title":"JAMA"},{"issue":"10240","key":"533_CR8","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","volume":"395","author":"J Burn","year":"2020","unstructured":"Burn J, Sheth H, Elliott F et al (2020) Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395(10240):1855\u20131863. https:\/\/doi.org\/10.1016\/S0140-6736(20)30366-4","journal-title":"Lancet"},{"key":"533_CR9","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric (version 1.2025). Available at: genetics_ceg.pdf. Accessed 1 July 2025"},{"issue":"4","key":"533_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10689-017-9986-9","volume":"16","author":"SG Smith","year":"2017","unstructured":"Smith SG, Foy R, McGowan J et al (2017) General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey. Fam Cancer 16(4):509\u2013516. https:\/\/doi.org\/10.1007\/s10689-017-9986-9","journal-title":"Fam Cancer"},{"issue":"3_suppl","key":"533_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1200\/JCO.2021.39.3_suppl.49","volume":"39","author":"MJ Hall","year":"2021","unstructured":"Hall MJ, Clapper M, Chang WCJ, Chertock Y, Nguyen MJ (2021) Predictors of uptake of aspirin (ASA) chemoprevention in Lynch syndrome (LS). J Clin Oncol. 39(3_suppl):49\u201349. https:\/\/doi.org\/10.1200\/JCO.2021.39.3_suppl.49","journal-title":"J Clin Oncol."},{"issue":"4","key":"533_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10689-013-9650-y","volume":"12","author":"J Burn","year":"2013","unstructured":"Burn J, Mathers JC, Bishop DT (2013) Chemoprevention in Lynch syndrome. Fam Cancer 12(4):707\u2013718. https:\/\/doi.org\/10.1007\/s10689-013-9650-y","journal-title":"Fam Cancer"},{"key":"533_CR13","doi-asserted-by":"publisher","first-page":"106872","DOI":"10.1016\/j.ypmed.2021.106872","volume":"154","author":"KE Lloyd","year":"2022","unstructured":"Lloyd KE, Hall LH, King N et al (2022) Aspirin use for cancer prevention: a systematic review of public, patient and healthcare provider attitudes and adherence behaviours. Prev Med (Baltim) 154:106872. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106872","journal-title":"Prev Med (Baltim)"},{"issue":"5","key":"533_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.amjcard.2012.04.045","volume":"110","author":"PT Nieuwkerk","year":"2012","unstructured":"Nieuwkerk PT, Nierman MC, Vissers MN et al (2012) Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol 110(5):666\u2013672. https:\/\/doi.org\/10.1016\/j.amjcard.2012.04.045","journal-title":"Am J Cardiol"},{"issue":"1","key":"533_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/2013.jamainternmed.717","volume":"173","author":"SF Derose","year":"2013","unstructured":"Derose SF, Green K, Marrett E et al (2013) Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med 173(1):38\u201343. https:\/\/doi.org\/10.1001\/2013.jamainternmed.717","journal-title":"JAMA Intern Med"},{"key":"533_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12875-016-0423-1","volume":"9","author":"BL Barfoed","year":"2016","unstructured":"Barfoed BL, Paulsen MS, Christensen PM, Halvorsen PA, Kj\u00e6r T, Larsen ML, Larsen PV, Nielsen JB, S\u00f8ndergaard J, Jarb\u00f8l DE (2016) Associations between patients\u2019 risk attitude and their adherence to statin treatment - a population based questionnaire and register study. BMC Fam Pract 9:17\u201328. https:\/\/doi.org\/10.1186\/s12875-016-0423-1","journal-title":"BMC Fam Pract"},{"key":"533_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/bdm.2215","volume":"34","author":"AN K\u00f6nig","year":"2021","unstructured":"K\u00f6nig AN (2021) Domain-specific risk attitudes and aging\u2014a systematic review. J Behav Decis Mak 34:359\u2013378. https:\/\/doi.org\/10.1002\/bdm.2215","journal-title":"J Behav Decis Mak"},{"issue":"6","key":"533_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/ijerph14060629","volume":"14","author":"M Del Rio","year":"2017","unstructured":"Del Rio M, Hargrove WL, Tomaka J, Korc M (2017) Transportation matters: a health impact assessment in rural New Mexico. Int J Environ Res Public Health 14(6):629. https:\/\/doi.org\/10.3390\/ijerph14060629","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"533_CR19","doi-asserted-by":"publisher","first-page":"gbad135","DOI":"10.1093\/geronb\/gbad135.","volume":"79","author":"J Yu","year":"2024","unstructured":"Yu J, Liu Y (2024) Barriers to transportation in rural communities: perspective of older adult users. J Gerontol B Psychol Sci Soc Sci 79(1):gbad135. https:\/\/doi.org\/10.1093\/geronb\/gbad135.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"3","key":"533_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","volume":"16","author":"DA Drew","year":"2016","unstructured":"Drew DA, Cao Y, Chan AT (2016) Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer 16(3):173\u2013186. https:\/\/doi.org\/10.1038\/nrc.2016.4","journal-title":"Nat Rev Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00533-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:59:26Z","timestamp":1770638366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00533-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00533-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7189423\/v1","asserted-by":"object"}]},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for conducting this study. Author Thomas Morland has received research support and has intellectual property interest from Tempus Labs, Inc. Author Thomas Morland also has an immediate family member that holds employment and is a shareholder of the United Therapeutics Corporation. Author Bradley Confer has been a consultant for Boston Scientific Corporation and participated in speaker\u2019s bureau at Abbvie. Author Hannah Woolley has an immediate family member who owns stock in Alcon, Novartis, Gilead Sciences, Regeneron, Amgen, Pfizer, Vertex Pharmaceutical, Biogen, BioNTech, and Moderna Therapeutics. Author Heather Rocha has an immediate family member who is employed by New York Presbyterian Hospital. All other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived by IRB of Geisinger in view of the retrospective nature of the study and all the interventions being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19"}}